Table 2.

Influenza vaccines marketed in the United States (2014–2015)

Product name	Manufacturer	Specification	Indications	Route
Standard dose of quadrivalent inactivated influenza vaccines.
Fluarix quadrivalent	GlaxoSmithKline	(Single dose) 0.5 ml/syringe	≥3 y	intramuscular
FluLava quadrivalent	ID company (GlaxoSmithKline)	(Single dose) 0.5 ml/syringe	≥3 y	intramuscular
		(Multiple doses) 5.0 ml/vial	≥3 y	intramuscular
Fluzone quadrivalent	Sanofi Pasteur	(Single dose) 0.25 ml/syringe	6–35 months	Intramuscular
		(Single dose) 0.5 ml/syringe	≥3 y	Intramuscular
		(single dose) 5.0 ml/vial	≥3 y	Intramuscular
		(Multiple doses) 5.0 ml/vial	≥5 months	Intramuscular
Standard dose of trivalent inactivated influenza vaccines
Afluria	CSL company	(Single dose) 0.5 ml/syringe (Needle-Free)	≥9 y	Intramuscular
		(Multiple doses) 5.0 ml/vial	≥9 y	Intramuscular
Fluarix	GlaxoSmithKline	(Single dose) 0.5 ml/syringe	≥3 y	Intramuscular
FluLaval	ID company (GlaxoSmithKline)	(Single dose) 0.5 ml/syringe	≥3 y	Intramuscular
		(Multiple doses) 5.0 ml/vial	≥3 y	Intramuscular
Fluvirin	Novartis	0.5 ml/syringe	≥4 y	Intramuscular
		5 ml/vial	≥4 y	Intramuscular
Fluzone	Sanofi Pasteur	(Single dose) 0.5 ml/syringe	≥3 y	Intramuscular
		(Multiple doses) 5.0 ml/vial	≥l months	Intramuscular
Fluzone Intradermal	Sanofi Pasteur	0.1 ml/Intradermal Needle	18 months –64 y	intracutaneous
Standard dose of trivalent inactivated influenza vaccines cultured from cells
Flucelvax	Novartis	0.5 ml/syringe	≥l8 y	Intramuscular
High doses of trivalent inactivated influenza vaccines
Fluzone High-dose	Sanofi Pasteur	0.5 ml/syringe	≥65 y	Intramuscular
Recombinant trivalent influenza vaccines
FluBlok	Protein Sciences	0.5 ml/vial	18–49 y	Intramuscular
Quadrivalent attenuated influenza vaccines
FluMist quadrivalent	AstraZeneca branch, Medimmune	0.2 ml/nasal spray	2–49 y	Nasal spray

Data source: Official websites of United States Food and Drug Administration.